Loading...
Keywords
Last Name
Institution
Back to Search Results

Connection

Search Results to Susana Chavez-Bueno

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Chavez-Bueno, Susana

PropertyValue
research overview Dr. Chavez-Bueno’s current research work focuses on the pathogenesis of E. coli sepsis in newborns. Her overall research goal is to identify novel virulence factors relevant to the pathogen’s ability to traverse the gut and invade the bloodstream causing neonatal sepsis. Her studies utilize in vitro and animal models designed to characterize the bacterial components that determine invasion and trafficking across intestinal epithelium and interact with gut specific immune regulators as potential therapeutic targets to decrease life-threatening neonatal E. coli disease. Dr. Chavez-Bueno is an elected member of the Society for Pediatric Research and member of the Infectious Diseases Society of America.

One or more keywords matched the following items that are connected to Chavez-Bueno, Susana

Item TypeName
Concept Animals
Concept Animals, Newborn
Concept Disease Models, Animal
Academic Article Chain length analysis of ADP-ribose polymers generated by poly(ADP-ribose) polymerase (PARP) as a function of beta-NAD+ and enzyme concentrations.
Academic Article Antimicrobial and immunologic activities of clarithromycin in a murine model of Mycoplasma pneumoniae-induced pneumonia.
Academic Article Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice.
Academic Article Treatment of experimental chronic pulmonary mycoplasmosis.
Academic Article Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation.
Academic Article Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model.
Academic Article Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency.
Academic Article Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia.
Academic Article Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia.
Academic Article Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model.
Academic Article Mycoplasma pneumoniae induces host-dependent pulmonary inflammation and airway obstruction in mice.
Academic Article Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model.
Academic Article Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.
Academic Article Respiratory syncytial virus persistence: evidence in the mouse model.
Academic Article Respiratory syncytial virus infections: old challenges and new opportunities.
Academic Article Respiratory syncytial virus pneumonia: mechanisms of inflammation and prolonged airway hyperresponsiveness.
Academic Article [Asthma and respiratory syncytial virus. New opportunities for therapeutic intervention].
Academic Article NEC-like intestinal injury is ameliorated by Lactobacillus rhamnosus GG in parallel with SIGIRR and A20 induction in neonatal mice.

Search Criteria
  • Animals